Detalles de la búsqueda
1.
Promoter hypermethylation of SFRP1 as a prognostic and potentially predictive blood-based biomarker in patients with localized pancreatic ductal adenocarcinoma.
Front Oncol
; 13: 1211292, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37333823
2.
Validation of SFRP1 Promoter Hypermethylation in Plasma as a Prognostic Marker for Survival and Gemcitabine Effectiveness in Patients with Stage IV Pancreatic Adenocarcinoma.
Cancers (Basel)
; 13(22)2021 Nov 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34830873
Resultados
1 -
2
de 2
1
Próxima >
>>